Pharmaron Biologics (UK) Ltd

Pharmaron Biologics is a world-class, strategic partner for Biologics Drugs – including Viral Vectors, Protein Therapeutics & Vaccines. We operate state-of-the-art cGMP biomanufacturing and standalone analytical facilities in Liverpool. We apply pharma industry-leading expertise and cutting-edge technologies to support customers develop, test and commercialise their innovative medicines.

Pharmaron is a premier service provider to the life sciences industry. Since our founding in 2004, we have invested significantly in our people and facilities, building end to end research, development, and manufacturing capabilities across the entire drug discovery, preclinical, and clinical development continuum. Our expertise spans multiple therapeutic modalities, including small molecules, biologics, and cell and gene therapy products. With more than 3,200 customers and 22,000 employees and operations in China, the U.S., and the U.K., Pharmaron has a strong track record of delivering high quality R&D solutions for partners across North America, Europe, Japan, and China.

Pharmaron Biologics brings 25 years of experience in developing and testing biologic medicines across a diverse portfolio. We are a world class centre for Viral Vectors, Protein Therapeutics, and Vaccines, with a proven history of successful delivery. Our Liverpool site features state of the art facilities, including advanced standalone analytical platforms, high throughput process development technologies, and a purpose designed biologics GMP manufacturing facility. Leveraging our global regulatory experience and deep technical expertise, we enable customers to develop innovative medicines with the potential to transform patient lives and deliver value for their organisations.

• Vaccines
• Virology
• Rare diseases
• Antibodies
• Biosimilars
• ATMP